Connection

Giuliano Rizzardini to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Giuliano Rizzardini has written about Antibodies, Monoclonal, Humanized.
Giuliano Rizzardini
Connection Strength
0.045
Antibodies, Monoclonal, Humanized
  1. Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy. Eur J Intern Med. 2020 06; 76:36-42.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.